NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Nicardipine Hydrochloride In 0.9% Sodium Chloride patents expire, and when can generic versions of Nicardipine Hydrochloride In 0.9% Sodium Chloride launch?
Nicardipine Hydrochloride In 0.9% Sodium Chloride is a drug marketed by Hikma Intl Pharms and is included in one NDA.
The generic ingredient in NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nicardipine Hydrochloride In 0.9% Sodium Chloride
A generic version of NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE was approved as nicardipine hydrochloride by ANI PHARMS on October 28th, 1996.
Summary for NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Clinical Trials: | 52 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE at DailyMed |
Recent Clinical Trials for NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Illinois at Chicago | Early Phase 1 |
| Nanjing First Hospital, Nanjing Medical University | N/A |
| Xiangtan Central Hospital | Phase 3 |
See all NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE clinical trials
Pharmacology for NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
US Patents and Regulatory Information for NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma Intl Pharms | NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 022276-002 | Apr 7, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hikma Intl Pharms | NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 022276-003 | Apr 7, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
